Trademarkia Logo

Canada

C$
Trademark Search in Canada
NOKSIPZA

View On IC.GC.CA

NOKSIPZA
REGISTERED

on 10 Sept 2019

Last Applicant/ Owned by

GREEN CROSS HOLDINGS CORPORATION A LEGAL ENTITY

107, Ihyeon-ro 30beon-gilGiheung-gu, Yongin-siGyeonggi-do

KR

Serial Number

1818309 filed on 16th Jan 2017

Registration Number

TMA1053573 registered on 10th Sept 2019

Registration expiry Date

10th Sept 2029

Correspondent Address

ROBIC AGENCE PI S.E.C./ ROBIC IP AGENCY LP

630, boul. René-Lévesque Ouest20e étageMontréal

QUÉBEC

CA

H3B1S6

NOKSIPZA

Trademark usage description

pharmaceuticals for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonar Read More

Classification Information

Class [001]
Chemicals and adhesives

Comment text

CIPO Classification Code

Classification kind code

Nice

Class [005]
Pharmaceuticals for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus, Hunter Syndrome, Hemophilia A, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, Clostridium tetani, influenza, and chronic pain, kidney diseases, ocular or intraocular surgery; Pharmaceutical preparations for use in chemotherapy, dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, urology; blood plasma-derivatives, namely albumins, immunoglobulins, and blood clotting factors; human vaccines, influenza vaccines and vaccine components; recombinant proteins, namely enzymes and blood clotting factors, for use in the medical and pharmaceutical industry; therapeutic antibodies for the prevention and treatment of Hepatitis B, influenza.

Classification kind code

11

Class [035]
Wholesale distributorships, namely, pharmaceutical products; retail store services, namely, pharmaceutical products; business agency services, namely, export and import agencies in the field of pharmaceutical products; wholesaling, distributing, and retailing of pharmaceutical products for others; pharmaceutical products procurement services for others, namely, purchasing pharmaceutical products for other businesses.

Classification kind code

11

Class [036]
Financial intermediary services, namely, facilitating the channeling of funds between lenders and borrowers by connecting those with a financial surplus with those having a financial deficit in the field of pharmaceutical products; financial intermediary services, namely, facilitating the channeling of funds between lenders and borrowers by connecting those with a financial surplus with those having a financial deficit in the field of medical machines and apparatus.

Classification kind code

11

Class [042]
Research and development in the field of pharmaceuticals, vaccines, plasma-derivatives, recombinant proteins and therapeutic antibodies; laboratory and scientific research in the field of pharmaceuticals, vaccines, plasma-derivatives, recombinant proteins and therapeutic antibodies.

Classification kind code

11

Mark Details

Serial Number

1818309

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 50
on 27th Jul 2018		Allowed
Submitted for opposition 51
on 27th Jul 2018		Allowance Notice Sent
Submitted for opposition 42
on 11th Apr 2018		Advertised
Submitted for opposition 26
on 22nd Mar 2018		Approved
Submitted for opposition 27
on 29th Jan 2018		Approval Notice Sent
Submitted for opposition 22
on 3rd Nov 2017		Search Recorded
Submitted for opposition 20
on 3rd Nov 2017		Examiner's First Report
Submitted for opposition 31
on 18th Jan 2017		Formalized
Submitted for opposition 1
on 17th Jan 2017		Created
Submitted for opposition 30
on 16th Jan 2017		Filed